142 related articles for article (PubMed ID: 37960805)
21. Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA.
Zhang M; Yang L; Wang Y; Zuo Y; Chen D; Guo X
Sci Rep; 2023 May; 13(1):7299. PubMed ID: 37147395
[TBL] [Abstract][Full Text] [Related]
22. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
Xiao B; Liu L; Li A; Wang P; Xiang C; Li H; Xiao T
Immun Inflamm Dis; 2021 Sep; 9(3):1044-1054. PubMed ID: 34077998
[TBL] [Abstract][Full Text] [Related]
24. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
[TBL] [Abstract][Full Text] [Related]
26. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis.
Zhang C; Dang D; Cong L; Sun H; Cong X
Cancer Med; 2021 Jul; 10(14):4710-4720. PubMed ID: 34159752
[TBL] [Abstract][Full Text] [Related]
27. Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma.
Niu L; Wu Z
Aging (Albany NY); 2023 May; 15(10):4236-4252. PubMed ID: 37211398
[TBL] [Abstract][Full Text] [Related]
28. Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers.
Shao T; Xie Y; Shi J; Yang C; Zou H; Li Y; Xu J; Li X
Commun Biol; 2022 Dec; 5(1):1324. PubMed ID: 36463330
[TBL] [Abstract][Full Text] [Related]
29. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X
Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683
[TBL] [Abstract][Full Text] [Related]
30. New algorithms based on autophagy-related lncRNAs pairs to predict the prognosis of skin cutaneous melanoma patients.
Liu Y; Zhang H; Hu D; Liu S
Arch Dermatol Res; 2023 Aug; 315(6):1511-1526. PubMed ID: 36624362
[TBL] [Abstract][Full Text] [Related]
31. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
32. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
Guo S; Chen J; Yi X; Lu Z; Guo W
Front Immunol; 2022; 13():985051. PubMed ID: 36248853
[TBL] [Abstract][Full Text] [Related]
33. Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma.
Sun D; Zhang C
Oncol Res; 2023; 31(5):753-767. PubMed ID: 37547766
[TBL] [Abstract][Full Text] [Related]
34. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
35. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
36. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
37. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
38. A Novel Risk Model Based on Autophagy-Related LncRNAs Predicts Prognosis and Indicates Immune Infiltration Landscape of Patients With Cutaneous Melanoma.
Shu Q; Zhou Y; Zhu Z; Chen X; Fang Q; Zhong L; Chen Z; Fang L
Front Genet; 2022; 13():885391. PubMed ID: 35571053
[TBL] [Abstract][Full Text] [Related]
39. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
40. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]